Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity

Metabolism: Clinical and Experimental
K TanakaY Takamura

Abstract

To determine whether impaired growth hormone (GH) secretion in obese subjects is a consequence of obesity or a pre-existing pituitary-hypothalamic disorder, we measured (1) plasma GH response to growth hormone-releasing hormone (GRH; 1 microgram/kg body weight [BW]), arginine (0.5 g/kg BW), and L-dopa (500 mg); and (2) plasma glucose, insulin, and free fatty acids (FFA) in obese subjects before and after weight reduction due to very-low-calorie diet therapy using Optifast (240 kcal/d for 8 to 12 weeks). Body weight and body mass index (BMI) values before and after weight reduction were 87.2 +/- 4.1 kg and 34.5 +/- 0.9 kg/m2, and 67.8 +/- 2.7 kg and 27.0 +/- 0.4 kg/m2, respectively. GH response to GRH, arginine, and L-dopa in obese subjects was markedly impaired before weight reduction, whereas significantly increased responses were noted after weight reduction (P less than .01). Impaired integrated GH response to GRH, arginine, and L-dopa in obese subjects was significantly restored after weight reduction (P less than .01). Plasma glucose levels did not change, while plasma insulin and FFA levels decreased significantly after weight reduction (P less than .01, P less than .05). There was no significant correlation between integ...Continue Reading

References

Sep 1, 1977·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·W M Fraser, W G Blackard
Aug 1, 1986·Endocrine Reviews·L A Frohman, J O Jansson
Jan 1, 1986·Annual Review of Physiology·M C Gelato, G R Merriam
Mar 1, 1986·The Journal of Clinical Endocrinology and Metabolism·K ChiharaT Fujita
Mar 1, 1988·The Journal of Clinical Endocrinology and Metabolism·M Kelijman, L A Frohman
Feb 1, 1985·The Journal of Clinical Endocrinology and Metabolism·T ImakiN Ling
Mar 1, 1985·The Journal of Clinical Endocrinology and Metabolism·A MasudaN Ling
Jan 1, 1971·The Journal of Clinical Endocrinology and Metabolism·A Z el-KhodaryJ J Canary
Jul 1, 1971·The Journal of Clinical Investigation·W G BlackardA Lopez
Jun 1, 1967·Metabolism: Clinical and Experimental·G CopinschiP H Forsham
Jan 1, 1981·Metabolism: Clinical and Experimental·A R GlassT M Boehm
Oct 1, 1980·Analytical Biochemistry·K MizunoH Hirakawa

❮ Previous
Next ❯

Citations

Aug 5, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J A KanaleyB Fernhall
Aug 1, 1996·Acta Paediatrica·A SartorioS Ferrero
Nov 5, 1998·Journal of Endocrinological Investigation·M CappaS Loche
Apr 1, 1996·Journal of Endocrinological Investigation·M MaccarioE Ghigo
Nov 3, 2009·Aging Cell·Leanne M RedmanUNKNOWN Pennington CALERIE Team
Aug 1, 1995·Metabolism: Clinical and Experimental·F VaccaroB Boscherini
Feb 4, 2005·Endocrine Reviews·Johannes D VeldhuisCyril Y Bowers
Jul 1, 1996·Psychological Medicine·P S DavisonE C Johnstone
Apr 30, 1999·Physiological Reviews·E E MüllerD Cocchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.